|
Volumn 291, Issue 5509, 2001, Pages 1692-1697
|
After a setback, gene therapy progresses ... Gingerly
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BLOOD CLOTTING FACTOR 8;
BLOOD CLOTTING FACTOR 9;
ADENOVIRUS;
COMBINED IMMUNODEFICIENCY;
GENE DELETION;
GENE INDUCTION;
GENE THERAPY;
GENE TRANSFER;
HEMOPHILIA;
HUMAN;
PRIORITY JOURNAL;
REVIEW;
TREATMENT OUTCOME;
ADENO ASSOCIATED VIRUS;
ANIMAL;
ARTICLE;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
CLINICAL TRIAL;
DOG;
FOOD AND DRUG ADMINISTRATION;
GENE VECTOR;
GENETICS;
GENETICS AND REPRODUCTION;
HEMOPHILIA A;
HEMOPHILIA B;
LIVER;
METABOLISM;
MUSCLE;
UNITED STATES;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
GENETICS AND REPRODUCTION;
ANIMALS;
CLINICAL TRIALS;
DEPENDOVIRUS;
DOGS;
FACTOR IX;
FACTOR VIII;
GENE THERAPY;
GENETIC RESEARCH;
GENETIC VECTORS;
HEMOPHILIA A;
HEMOPHILIA B;
HUMANS;
LIVER;
MUSCLES;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 0035794115
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.291.5509.1692 Document Type: Review |
Times cited : (16)
|
References (0)
|